A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers
暂无分享,去创建一个
E. Schadt | F. Hirsch | Rong Chen | P. Mack | S. Newman | K. Ayers | J. J. Liu | Meng Ma | S. Li | Gaspard Debussche | Xiang Zhou | J. McCafferty | D. Corrigan | Kyeryoung Lee | J. Liu | F. Hirsch